IGLC2 and COVID-19: Moreover, IGLC2 has been highlighted as upregulated in the form of transcript in B-cells of SARS-CoV-2 patients [29], and as a protein in sera of COVID-19 patients, where its level has not been normalised after patient recovery [31].